|
gptkb:CHEMBL1130
|
hypertension
|
|
gptkb:CHEMBL368
|
gptkb:hypereosinophilic_syndrome
|
|
gptkb:Phesgo
|
gptkb:HER2-positive_breast_cancer
|
|
gptkb:Giotrif
|
gptkb:EGFR_mutation-positive_NSCLC
|
|
gptkb:ChEMBL1044
|
hypertension
|
|
gptkb:Sustainable_Development_Goal_2
|
Proportion of agricultural area under productive and sustainable agriculture
|
|
gptkb:Epanova
|
severe hypertriglyceridemia
|
|
gptkb:Reduced_Inequalities_(SDG_10)
|
10.c.1
|
|
gptkb:Meningitec
|
adolescents
|
|
gptkb:CHEMBL413
|
angina pectoris
|
|
gptkb:AUGMENT_Bone_Graft
|
patients with insufficient autograft material
|
|
gptkb:Ingelvac_CircoFLEX
|
reduction of viraemia caused by PCV2
|
|
gptkb:PEG-INTRON
|
gptkb:chronic_hepatitis_C
|
|
gptkb:Gensulin_M30
|
gptkb:diabetes_mellitus
|
|
gptkb:high-sensitivity_CRP_test_(hs-CRP)
|
risk of heart attack
|
|
gptkb:Lumicell_Imaging_System
|
breast cancer surgery
|
|
gptkb:DB01261
|
diabetic peripheral neuropathic pain
|
|
gptkb:Ribociclib
|
HER2-negative breast cancer
|
|
gptkb:Intelence
|
treatment-experienced HIV-1 patients
|
|
gptkb:Non-GMO_Project_Verified_products
|
absence of genetically modified organisms
|